Peer Review History
| Original SubmissionMarch 4, 2025 |
|---|
|
Dear Dr. Ishihara, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Please submit your revised manuscript by May 07 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Amr Ehab El-Qushayri Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that there are restrictions to data sharing for this study. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Before we proceed with your manuscript, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., a Research Ethics Committee or Institutional Review Board, etc.). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. You also have the option of uploading the data as Supporting Information files, but we would recommend depositing data directly to a data repository if possible. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. Additional Editor Comments: I would congratulate the authors for their paper. I had few comments in addition to the reviewers' comments: 1-Please indicate the grade of pneumonia (mild, moderate or severe) since it can affect the level of physical activity. 2-Please indicate the method of pneumonia treatment as it also affect the level of physical activity. Did any patient receive mechanical ventilation,...etc 3-There is a major limitation here that could turn your results to be insignificant which is the comorbidity and the elder age. Many patients had stroke, malignancy, even severe cases of pneumonia,..etc. Those patients would have low physical activity whether they own pets or no. Please elaborate in discussion and also explain this in conclusion for future studies as this is a strong limitation in your study. 4-Rewrite the conclusion since it is firm while you had many limitations that would turn the results upside down if a new study have addressed them well. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: Clarity: The article is well-written, with concise and coherent language. Argument Strength: While arguments are clear, the idea lacks strong significance. Research Quality: It features robust statistics, solid methodologies, and credible sources. Limitations: Thoughtful limitations are acknowledged, enhancing credibility. Relevance: The topic holds less importance due to existing hospital rules about pets. Structure: The introduction, results, and conclusion are logically and effectively organized. Style and Tone: The language is appropriate and tailored for a diverse audience Reviewer #2: The study has a good methodological design, particularly for its use of Directed Acyclic Graphs (DAGs) and a detailed flowchart outlining the study process. Incorporating DAGs to visually represent assumptions about causal relationships enhances the transparency and rigor of the analysis, allowing readers to clearly understand the rationale behind variable selection and adjustment strategies. Additionally, the inclusion of a study flowchart provides valuable clarity regarding participant selection, exclusions, and key study stages. However, these are my comments Introduction: Please add more information about Barthel index Methods: 90-97 The authors report that they searched electronic medical records using Japanese terms such as “pet,” “dog,” “cat,” “ownership,” and “keeping,” in combination with the insurance disease name “pneumonia” to identify eligible patients. However, this approach raises some concerns regarding the reliability and reproducibility of case identification. Specifically, Japan employs a standardized coding system (e.g., ICD-10 codes) in its national health insurance claims data, which should provide a more accurate and systematic method for identifying cases of pneumonia. It is unclear why the authors chose to rely on keyword searches in the free text or insurance disease name fields rather than using established diagnostic codes. Using text-based searches may increase the risk of selection bias or misclassification, particularly if terminology varies among physicians. Moreover, this method could miss cases that are coded appropriately but do not contain the exact keywords used, or could include cases that mention the keywords without confirming a true diagnosis. To enhance methodological rigor and reproducibility, the authors should justify this choice and, if possible, demonstrate the validity of their text-based approach compared to standard coding methods. Moreover, BI scores were recorded based on physical therapists’ notes, but it does not mention whether these assessments were standardized or validated across therapists. This raises concerns about inter-rater reliability. 99-106: Why the author choose specific comorbidities and omit others like chronic kidney disease or heart failure, Also, psychiatric disease should be specified as this term is too broad (depression, anxiety and so on) 135-142 The DAG may omit key confounders that could affect both pet ownership and physical function. For example, socioeconomic status, baseline physical activity, or cognitive function might influence both exposure and outcome. Additionally, as a reader, I would appreciate a clearer explanation of the rationale behind the selection of adjustment variables. For example, it is unclear why psychological status was not included—was it considered a collider or irrelevant in the causal pathway? Including this type of justification would strengthen the methodological transparency. It would also be helpful if the DAGs were labeled to indicate the role of each variable (e.g., confounder, mediator, collider), which would make it easier to understand the assumptions guiding the adjustment strategy. 144-156 It is important to note that gender and sex represent distinct concepts; in the DAGs, gender was depicted, while the Methods section reported on sex. Results: 196 While the authors present main regression outcome in the results section, they do not provide the complete regression table, including all covariates, their coefficients, confidence intervals, and p-values. Discussion 213-219 252-254: why it is difficult to include those variables ? Figure 2 shows that 62 patients were excluded from the analysis due to the absence of rehabilitation records. While this criterion is understandable for ensuring data completeness, such an exclusion could introduce selection bias if the lack of rehabilitation records is not random. For example, patients without rehabilitation records may differ systematically from those with records in terms of disease severity, functional status, or access to care. This could potentially bias the results and affect the generalizability of the findings. The authors should acknowledge this as a limitation in the discussion section. Additionally, they could provide a brief comparison of baseline characteristics between included and excluded patients to assess the potential for bias. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Ishihara, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 30 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Amr Ehab El-Qushayri Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: No Reviewer #3: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #2: For comment "METHOD: The DAG may omit key confounders that could affect both pet ownership and physical function. For example, socioeconomic status, baseline physical activity, or cognitive function might influence both exposure and outcome. Additionally, as a reader, I would appreciate a clearer explanation of the rationale behind the selection of adjustment variables. For example, it is unclear why psychological status was not included—was it considered a collider or irrelevant in the causal pathway? Including this type of justification would strengthen the methodological transparency. It would also be helpful if the DAGs were labeled to indicate the role of each variable (e.g., confounder, mediator, collider), which would make it easier to understand the assumptions guiding the adjustment strategy." While I appreciate the inclusion of labeled DAGs and partial rationale in the Methods section, the justification for selecting only three adjustment variables remains insufficient. Psychological status was excluded due to lack of data, rather than a theoretical justification based on the causal framework. Additionally, including the Pneumonia Severity Index (PSI) as an adjustment variable—despite acknowledging it may act as a mediator—raises concerns about potential bias from conditioning on a variable in the causal pathway. The rationale for estimating a direct versus total effect is not discussed. I encourage the authors to: Justify the inclusion of PSI under this estimand; More comprehensively discuss why other plausible confounders (e.g., SES, baseline physical activity, cognitive function) were excluded; If model complexity was a constraint, please report the sample size and modeling approach used to evaluate overfitting. Reviewer #3: lines 139-140: you mentioned that Pneumonia severity may act as a mediator and a previous statement is that Pet ownership is unlikely to influence the severity of Pneumonia. A mediator should be in the middle of the pathway between ethe exposure and the outcome. If Pneumonia was not caused by pet ownership it cant be a mediator. However, you can still adjust for it if it causes the outcome; so no need to change the analysis. Fig1: any Inclusion or exclusion that happens on future events after the exposure can cause "Immortal time Bias"; lacking records of pet ownership and being hospitalized for the first time happens at the admission. Records missing should be treated as data missing not as an exclusion criteria. Patients that died during hospitalization should still be included and then censored at death. Please update the graph and the analysis accordingly. The graph should have no conditioning on future events (i.e. no inclusion, or exclusion criteria on the follow up period), and the characteristics table (the analysis) should include patients who owns pets upon admission, later on, if death occurs, they may be censored. Meaning they should be added to the baseline variables calculations, and then censored at the outcome. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: Yes: Ahmed Mostafa Ahmed Kamel ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 2 |
|
Association between Pet Ownership and Physical Function at Discharge in Hospitalized Older Adults: A Retrospective observational study PONE-D-25-10406R2 Dear Dr. Ishihara, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Amr Ehab El-Qushayri Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #2: (No Response) Reviewer #3: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: No ********** |
| Formally Accepted |
|
PONE-D-25-10406R2 PLOS ONE Dear Dr. Ishihara, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Amr Ehab El-Qushayri Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .